C4161007

The Pfizer Clinical Research Unit is conducting a clinical trial with healthy volunteers to compare different forms of an oral study drug for certain types of cancer. This study will also look at the effect of food on the metabolism of one formulation.

The study drug is being evaluated for the treatment of cancers with specific types of tumors, including ovarian and breast cancers. Affected patients are in need of effective and safe treatments, and healthy volunteers are an important part of developing these medicines.

Read more about this study below and see if you can make a difference as a healthy volunteer.

Card Summary Component

Who may participate

Joining a clinical trial is an important and personal decision. We hope it is one you will consider. This study is seeking healthy adult volunteers, meaning that the participants will not have the condition being studied and are in overall good health. In addition to the criteria listed, participants must meet the following requirements:

  • Willing to take a study drug
  • Able to comply with all study procedures
  • Willing to travel to our facility in New Haven, CT*

*eligible volunteers may receive a bonus for travel to and from the PCRU.

There are other requirements for participation in this study. The study staff will explain these to you during the screening process.

 

Do you know someone who may meet these requirements? Refer a friend and you may be eligible to receive a bonus.

Condition

Healthy

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Age

18-60 years

The age a person must be to participate in a clinical trial.

Sex

Male

The sex of people who may participate in a clinical trial. Sex is a person’s classification based on assignment at birth. Eligibility based on sex is distinct from eligibility based on gender.

Referral bonus

Up to $150

Click “learn more” for program details. Compensation may be provided on a loadable debit card or by paper check in US dollars. The New Haven PCRU reserves the right to determine method of payment, determine eligibility, or change or terminate this program at any time.

Each clinical study has its own guidelines for who can participate, called eligibility criteria. However, only the research study staff can determine if you qualify to enroll in the study.

What to expect

If this study may be a fit for you, you’ll be invited to a screening visit at our facility in New Haven, CT. If you qualify for the study, there may be a period of up to 28 days before dosing.

If you choose to participate, you will stay at our facility for 18 consecutive overnights. During your stay, you will receive doses of the study drug as various oral tablets once every 5 days starting the morning after admission, up to 4 total doses. Most of the doses will be taken on an empty stomach, but with the last dose you may be provided breakfast.

Throughout the study, staff will closely monitor your health status and collect data, such as the levels of the study drug in your blood.

Required overnight stays

18

A participant may be required to stay overnight at the PCRU for observation and study procedures. The number and length of overnight stays is determined by the design of the study.

Long-term follow up

1 phone call

Some studies require the study team to stay in contact with the participant for a period of time after the participant completes the main part of the study. This long-term follow up is to collect additional information on the study drug over time.

How long is this study?

About 45 days

This is the time between admission and final follow-up call or visit. This does not include the time between screening and dosing, which can be up to 28 days.

Compensation

Up to $6,175 upon completion of the study

Participants in clinical trials at the PCRU receive financial compensation for their participation. The amount depends on factors like length of the stay, total number of study visits, and the nature of the study procedures.

All of the study procedures will be clearly explained to you during screening and can be viewed by downloading the informed consent form.

Safety remains our top priority at the PCRU during COVID-19
Learn about how we’re keeping participants and staff safe

Interested in participating?

Complete and submit this form, and a Pfizer New Haven Clinical Research Unit (PCRU) representative will contact you. Please note: volunteers completing this form must be able to read and speak English at an 8th grade level.

You may also call 1-800-254-6398 and speak with a PCRU representative to learn more.

For Japanese language assistance only, please call 1-833-711-9984. We apologize, our representatives cannot take calls in languages other than English or Japanese at this time.

The personal data gathered here will be collected, processed, and maintained in a confidential manner. Your information will be stored in our research unit’s database. We may use this information to invite you to participate in current and future clinical studies at the PCRU. You will have full access to your records at the Pfizer New Haven Clinical Research Unit and the opportunity to correct them if necessary.

Cancel